Neuroendocrinological mechanisms of actions of antidepressant drugs.
about
5-HT(1A) receptor function in major depressive disorderIs increased antidepressant exposure a contributory factor to the obesity pandemic?Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patientsA final common pathway for depression? Progress toward a general conceptual framework.The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depressionPathophysiology of depression: do we have any solid evidence of interest to clinicians?Clinical applications of hallucinogens: A review.Effects of selective serotonin reuptake inhibitor treatment on plasma oxytocin and cortisol in major depressive disorderInfluence of sex and stress exposure across the lifespan on endophenotypes of depression: focus on behavior, glucocorticoids, and hippocampus.Sex differences in cortisol response to corticotropin releasing hormone challenge over puberty: Pittsburgh Pediatric Neurobehavioral Studies.A placebo-controlled study of sertraline's effect on cortisol response to the dexamethasone/corticotropin-releasing hormone test in healthy adultsCorticosterone exposure augments sensitivity to the behavioral and neuroplastic effects of fluoxetine in C57BL/6 miceComputational models of neuronal biophysics and the characterization of potential neuropharmacological targets.Salivary cortisol in women with major depressive disorder under selective serotonin reuptake inhibitors therapy.Epigenetic Modulation of Mood Disorders.The neural plasticity theory of depression: assessing the roles of adult neurogenesis and PSA-NCAM within the hippocampus.A final common pathway for depression: implications for therapy.Plasma cortisol in Alzheimer's disease with or without depressive symptomsElectroencephalographic sleep and hypothalamic-pituitary-adrenal changes from episode to recovery in depressed adolescents.Increased hippocampal neurogenesis and p21 expression in depression: dependent on antidepressants, sex, age, and antipsychotic exposure.Suppression of the MEK/ERK signaling pathway reverses depression-like behaviors of CRF2-deficient mice.Early life stress as an influence on limbic epilepsy: an hypothesis whose time has come?Salivary alpha-amylase and cortisol responsiveness following electrically stimulated physical stress in bipolar disorder patients.Oestrogen: an overlooked mediator in the neuropsychopharmacology of treatment response?Reconsidering GHB: orphan drug or new model antidepressant?Biological indicators of illness risk in offspring of bipolar parents: targeting the hypothalamic-pituitary-adrenal axis and immune system.Stress-related depression: neuroendocrine, genetic, and therapeutical aspects.Sex, hormones and neurogenesis in the hippocampus: hormonal modulation of neurogenesis and potential functional implications.Psychiatric neural networks and neuropharmacology: Selected advances and novel implicationsHypothalamic-pituitary-adrenocortical axis: neuropsychiatric aspects.Influence of genetic polymorphisms involved in the hypothalamic-pituitary-adrenal axis and their interactions with environmental factors on antidepressant response.Tryptophan: the key to boosting brain serotonin synthesis in depressive illness.Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease.Hypothalamic-pituitary-adrenocortical system dysregulation and new treatment strategies in depression.Shifting the balance of brain tryptophan metabolism elicited by isolation housing and systemic administration of lipopolysaccharide in mice.HPA axis reactivity to pharmacologic and psychological stressors in euthymic women with histories of postpartum versus major depression.Prescription of antidepressants is increased in Danish patients with polycystic ovary syndrome and is associated with hyperandrogenism. A population-based cohort study.Association between cortisol awakening response and memory function in major depression.The association of proopiomelanocortin polymorphisms with the risk of major depressive disorder and the response to antidepressants via interactions with stressful life events.
P2860
Q24643511-05536CDF-81CD-4EEF-8857-0CF6E2656067Q26765430-C1368DB8-4B69-422D-B39C-A313E9BD6A2DQ28478124-05FC5763-FCAF-4F85-B701-147044AF8E80Q30491982-C7B00608-5DB4-4F3A-8876-C17418EE67EBQ33403748-12A22DFD-EA99-4B5C-B63A-9CF32954C511Q34145754-4CAF0155-EE9C-4EBC-8418-7644EA7BEBCBQ34535259-5CECE7E0-26D1-4AEE-B29D-029DBBB4B0B9Q34694131-49CCA5EE-9112-4464-8028-F62053BAC1E2Q34840916-AE3288E0-9E03-4C7B-A841-1ADBA2B33837Q35726794-AD1ECC17-CE4B-4F8F-82B7-8EF6FEB6348DQ35743599-AB0615F3-A818-495E-B87A-2A7B66960396Q36514005-472D9174-EDE6-4BEF-A718-4EEEDC3A355EQ36576250-DCEFF548-3701-4C18-8CAD-C1AB550297E9Q36676338-034E64A7-D4C3-4743-8880-084C62A025D9Q36737217-523DB026-C9EE-4510-BAC8-D6B46637C552Q36830911-F2B2B9B7-6C23-48D1-87B5-92E6A72A6F90Q36897335-632F87D3-8DD3-45DF-95A5-943C18AE209DQ37115456-92892AD5-3CE5-44E1-A9B0-2FF9B2409155Q37166797-A4EE43D6-833C-44B9-BDF7-D2D342414910Q37172784-5424185D-05BF-43CA-AE0B-5F53DB94EF5FQ37187299-A604D12F-8917-43B2-96E2-06951C60F89DQ37388479-882C8E6C-7198-41FA-B4F2-86C1FA7439D0Q37390497-B5A39DC6-B9D9-48B2-8744-C70D2BC31C35Q37791238-C2A71294-C16C-497B-A559-7969F51538ACQ37934335-C076E765-3B0B-4766-AD88-47500F613EF4Q37969810-FA471FEC-29F7-4433-9805-014993C02AF5Q38016982-1412E5EB-883A-4EA2-B33F-AB6C8BA78C5CQ38119012-002A0FF5-5F1C-4C73-844B-8A2FAF4782B9Q38197608-3C6E64B3-C127-42B9-B2C0-2A60441C2844Q38203227-00097F3A-6834-4A32-A1B8-7FAC343841EAQ39034597-2A1421E8-DDE4-4662-BA0F-ED4315B3763FQ39374641-BAD2CF64-3BD5-43FB-811C-AF7D7E781520Q43135405-EB91126B-DAAE-4649-8505-1D595D121787Q45916411-856B3B38-6B69-4996-90F5-DF3AFE33040AQ45934195-17672338-E29E-4B25-B09A-B8AE7EF8B5EDQ46249577-DAF92D0E-3711-4364-883C-AF922EF4F45CQ47957126-932F78B6-396B-4895-BE5D-08974644DE29Q48135858-2D08E75B-3356-4C03-8AD6-03AA8239D19AQ48148070-CA20869E-4A39-479D-8DCF-3B0B0099E92FQ48164870-E389E01A-E53A-44A2-9FC5-71A27703B13C
P2860
Neuroendocrinological mechanisms of actions of antidepressant drugs.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Neuroendocrinological mechanisms of actions of antidepressant drugs.
@ast
Neuroendocrinological mechanisms of actions of antidepressant drugs.
@en
type
label
Neuroendocrinological mechanisms of actions of antidepressant drugs.
@ast
Neuroendocrinological mechanisms of actions of antidepressant drugs.
@en
prefLabel
Neuroendocrinological mechanisms of actions of antidepressant drugs.
@ast
Neuroendocrinological mechanisms of actions of antidepressant drugs.
@en
P2860
P1476
Neuroendocrinological mechanisms of actions of antidepressant drugs.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2826.2006.01516.X
P577
2007-03-01T00:00:00Z